Professor Scott Bell
Scott is the Chief Executive of the Translational Research Institute and a Senior Physician of the Adult Cystic Fibrosis Centre at The Prince Charles Hospital in Brisbane where he has worked since 1996. He leads the Lung Bacteria Laboratory at The University of Queensland’s Children’s Health Research Centre.
Scott has over 250 peer-reviewed publications and has received grant support of more than $22 million over the past 10 years. His research interests include CF microbiology, acquisition pathways for human infection and he has a long history of supporting multi-disciplinary research.
He has been principal investigator on numerous pivotal CFTR modulator trials and is global principal investigator on a novel approach to combination therapies for CFTR correction. He has been the Editor-in-Chief of the Journal of Cystic Fibrosis since 2013.
Health Translation Queensland acknowledges the Traditional Owners and their custodianship of the lands on which we live, work, and play. We pay our respects to their Ancestors and their descendants, who continue cultural and spiritual connections to Country. We recognise their valuable contributions to Australian and global society.